Latest Capital Raises News

Page 18 of 654
VEEM Limited reports half-year revenue close to guidance with improved cash flow, offset by a significant $24.8 million non-cash impairment tied to its gyro product upgrade. The transition to the new Mark III gyro design has temporarily stalled sales as customers await delivery.
Victor Sage
Victor Sage
23 Feb 2026
Barton Gold Holdings has distributed over $640,000 in Junior Minerals Exploration Incentive tax credits to investors from its June 2025 placement, enhancing returns amid strong exploration activity.
Maxwell Dee
Maxwell Dee
23 Feb 2026
EMVision Medical Devices reported a $3.97 million loss for H1 2026, up 11% year-on-year, driven by increased share-based payments and expanded clinical activities. The company secured a $3 million government grant to advance stroke diagnosis in regional Australia.
Ada Torres
Ada Torres
23 Feb 2026
Genesis Energy has reported a record first-half normalised EBITDAF of NZ$307 million, underpinned by strong hydro inflows and portfolio flexibility, while announcing a $400 million equity raise to accelerate its renewable growth strategy.
Maxwell Dee
Maxwell Dee
23 Feb 2026
Deal headlines and big drill hits shared the stage with a brutal sell-off in a handful of tiny raisings. The week’s biggest winners were backed by clear news; the biggest losers showed what happens when buyers vanish after a halt.
Logan Eniac
Logan Eniac
21 Feb 2026
Big gains hit wealth platforms while Zip swung the other way as early optimism didn’t stick. Dividends and buy-backs kept coming, but investors still punished stocks where the next step looks unclear.
Logan Eniac
Logan Eniac
21 Feb 2026
Small caps stole the spotlight, with a handful of stocks doubling on deal news and early-stage project updates. Large miners were steadier, but even they couldn’t fully escape the week’s sharp gap moves.
Logan Eniac
Logan Eniac
21 Feb 2026
Two capital raisings and one brutal reset set the tone, even as several companies posted clean growth or strong clinical updates. Radiopharmaceuticals kept delivering good news, but investors still punished supply-chain and cash needs fast.
Logan Eniac
Logan Eniac
21 Feb 2026
FortifAI’s funding and big claims around faster AI data processing drove the week’s loudest move, while two small caps jumped on price queries. Elsewhere, results season rewarded clear recurring revenue growth, but punished gaps where early buying didn’t stick.
Logan Eniac
Logan Eniac
21 Feb 2026
Aurora Labs reported a 15% revenue decline and a 12% increase in net loss for H1 2026, yet marked a strategic breakthrough with its first defence propulsion order and a successful $5.5 million capital raise.
Victor Sage
Victor Sage
20 Feb 2026
Multistack International Limited posted a surprising $2.26 million net profit for 2025, driven by one-off settlement income, while its core operations continue to falter, prompting plans to exit its current business model.
Victor Sage
Victor Sage
20 Feb 2026
Imperial Pacific Limited reported a half-year net profit of $148,000 for the six months ending December 2025, supported by strong asset growth and a fully franked 7 cent dividend. The company’s portfolio, including stakes in London City Equities and Excelsior Capital, drove net asset value to record highs despite a dip in profit.
Claire Turing
Claire Turing
20 Feb 2026